We have found that MSLN can regulate EMT of tumor cells, associated with chemotherapy resistance and pancreatic cancer cells with high levels of MSLN have stronger proliferation and invasion to promote tumor development. This evidence concerns the gene MSLN and pancreatic neoplasm.